Significant differences were found between myocardial infarction (p = 0.040), cardiovascular mortality (p = 0.006), and MACE (p = 0.009) in CHD patients with hs-CRP levels above and below 0.3 mg/dL (Table 3). This evidence concerns the gene CRP and myocardial infarction.